Malignancy and immunosuppression.
作者信息
Kinlen L J
出版信息
Proc R Soc Med. 1972 Mar;65(3):242. doi: 10.1177/003591577206500305.
Abstract
摘要
相似文献
1
Malignancy and immunosuppression.恶性肿瘤与免疫抑制。
Proc R Soc Med. 1972 Mar;65(3):242. doi: 10.1177/003591577206500305.
2
Immunosuppression and malignancy.免疫抑制与恶性肿瘤。
Br Med J. 1972 Sep 23;3(5829):713-4.
3
[Lymphomata in patients with kidney transplantation].
Harefuah. 1972 May 15;82(10):474-5.
4
Tumour development following immunosuppression.免疫抑制后的肿瘤发展。
Proc R Soc Med. 1970 Oct;63(10):1077-80. doi: 10.1177/003591577006301055.
5
Cancer and survival after cadaveric donor renal transplantation.尸体供肾移植后的癌症与生存情况
Transplant Proc. 1979 Mar;11(1):1052-4.
6
Another look at immunologic surveillance.再看免疫监视。
N Engl J Med. 1975 Jul 24;293(4):181-4. doi: 10.1056/NEJM197507242930406.
7
Increasing transplant cancer patient survival by conversion of immunosuppressive agents.
Transplant Proc. 1996 Jun;28(3):1346-7.
8
A hematologist's appraisal of the problem cerebral lymphomas in transplanted patients. A speculative review.血液学家对移植患者中脑淋巴瘤问题的评估。一篇推测性综述。
Haematologica. 1974 Dec;59(4):489-98.
9
[Malignant tumors under immunosuppression, a new problem in transplant-recipients].[免疫抑制状态下的恶性肿瘤，移植受者面临的新问题]
Helv Chir Acta. 1973 Dec;40(5):773-6.
10
Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
Transplant Proc. 1993 Jun;25(3):2302.
本文引用的文献
1
Immunosurveillance and cancer: epidemiological evidence.免疫监视与癌症：流行病学证据
Br Med J. 1970 Nov 14;4(5732):420-2. doi: 10.1136/bmj.4.5732.420.
Zotero 插件